Concepedia

Publication | Open Access

Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer

DOIFull Paper Access

153

Citations

40

References

2015

Year

Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley, Koleen Eisele, Todd VanArsdale, Stephen G. Dann, Kim Arndt, Tina Primeau, Elizabeth Griffin, Jieya Shao,
Clinical Cancer Research

Abstract

A SERD- or SSH-palbociclib combination has therapeutic potential in breast tumors resistant to endocrine therapies or those expressing ESR1 mutations. See related commentary by DeMichele and Chodosh, p. 4999.

References

YearCitations

Page 1